Exclusive to Profit Confidential

“ODD Loophole”
Millionaire Maker Event

Tuesday, October 11, 2016, 10:30 a.m. EST

Dear Friend:

Biotech companies that get “ODD” status are almost guaranteed market dominance by the Food and Drug Administration.

Some are just tiny new IPOs trading for under $5 and in the clinical stage of testing a new drug that’s highly urgent.

Once their drugs are approved, a kind of ripple effect takes place... where the companies that develop and get approval for these drugs often see their stock prices soar for potentially massive gains.

I’ve used the “ODD Loophole” to help me post these gains on biotech stocks:

1,766% on Jazz Pharmaceuticals
755% on Cambrex
321% on Alkermes
643% on Isis Pharmaceuticals
524% on PAREXEL

In my presentation on Tuesday, October 11, 2016, I reveal exactly how the “ODD Loophole” works and the companies that I believe are next to get their drugs through the FDA approval process courtesy of the “ODD Loophole.”

In particular there is one company I’m tracking right now that could soon get its essential drug approved. I expect the company’s stock to skyrocket when that happens.

However, I must strictly limit the
number of attendees to this event to only
1,000 of my Profit Confidential readers

While I truly want to share my “ODD Loophole Millionaire Maker” event with all my customers, I can’t risk too many people chasing the companies that are next in line to get their drugs fast tracked through the FDA approval process courtesy of the “ODD Loophole.” Hence, I am only sharing it with 1,000 people.

That means only a small fraction of our readers are going to be able to register for this event.

This is why it’s vital you secure your spot immediately.

To secure your seat, just fill out the easy registration form below.

Just enter your first name and e-mail address below. We will save your seat and send you instructions on how to attend this online presentation on October 11th.